2026-09-19T15:36:16Zhttps://dspace.mit.edu/server/oai/requestoai:dspace.mit.edu:1721.1/442852022-01-13T07:54:23Zcom_1721.1_7582com_1721.1_7581col_1721.1_131023
Donald B. Rosenfield and Fred Moavenzadeh.
Kristinsdottir, Asbjorg
Massachusetts Institute of Technology. Dept. of Civil and Environmental Engineering.
Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
2009-01-30T16:28:09Z
2009-01-30T16:28:09Z
2008
2008
http://hdl.handle.net/1721.1/44285
269366461
Thesis (S.M.)--Massachusetts Institute of Technology, Dept. of Civil and Environmental Engineering, 2008.
Includes bibliographical references (p. 61-62).
The biotechnology industry has experienced fast growth during the first 30 years of its existence but is now reaching a stage of maturity. Companies are being challenged by weak pipelines and patent expirations, as well as increasing regulation. Mergers and acquisitions are frequent, and companies are forced to reduce planned capital expenditures, as well as restructure with personnel cuts and facility reductions. This thesis focuses on the affect those changes are having on the development of capital projects. It researches the environment as it used to be and what is now bringing the changes. Through literature search and case study, the thesis aims to capture the reasons for why the main driver of new facilities construction has shifted from time to cost and the affect that is having on the management and delivery of such projects.
by Asbjorg Kristinsdottir.
S.M.
62 p.
eng
Massachusetts Institute of Technology
M.I.T. theses are protected by
copyright. They may be viewed from this source for any purpose, but
reproduction or distribution in any format is prohibited without written
permission. See provided URL for inquiries about permission.
http://dspace.mit.edu/handle/1721.1/7582
Civil and Environmental Engineering.
Capital project development in biotechnology industry
Thesis
application/pdf
false
Publication
unknown
unknown
<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="fddad6e1-3632-4d7b-8bf6-7165d4b09d92">
<Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type>
<Language>eng</Language>
<Title>Capital project development in biotechnology industry</Title>
<PublishedIn>
<Publication>
</Publication>
</PublishedIn>
<PublicationDate>2008</PublicationDate>
<Authors>
<Author>
<DisplayName>Kristinsdottir, Asbjorg</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
</Authors>
<Editors>
</Editors>
<Publishers>
<Publisher>
<DisplayName>Massachusetts Institute of Technology</DisplayName>
<OrgUnit />
</Publisher>
</Publishers>
<License>http://dspace.mit.edu/handle/1721.1/7582</License>
<Keyword>Civil and Environmental Engineering.</Keyword>
<Abstract>The biotechnology industry has experienced fast growth during the first 30 years of its existence but is now reaching a stage of maturity. Companies are being challenged by weak pipelines and patent expirations, as well as increasing regulation. Mergers and acquisitions are frequent, and companies are forced to reduce planned capital expenditures, as well as restructure with personnel cuts and facility reductions. This thesis focuses on the affect those changes are having on the development of capital projects. It researches the environment as it used to be and what is now bringing the changes. Through literature search and case study, the thesis aims to capture the reasons for why the main driver of new facilities construction has shifted from time to cost and the affect that is having on the management and delivery of such projects.</Abstract>
<Access xmlns="http://purl.org/coar/access_right"
>
</Access>
</Publication>